LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Relative Growth Rate After Treatment
BT-20 HG-6-64-01
3.33
uM
LJP6
 2
M02
 72
hr
 1657 3216 5505 0.5841 0.4050
BT-20 HG-6-64-01
3.33
uM
LJP6
 3
M02
 72
hr
 1657 2831 5505 0.5142 0.3049
BT-20 WH-4-025
3.33
uM
LJP5
 1
O08
 72
hr
 1657 1224 5505 0.2223 -0.1127
BT-20 WH-4-025
3.33
uM
LJP5
 2
O08
 72
hr
 1657 1632 5505 0.2964 -0.0067
BT-20 WH-4-025
3.33
uM
LJP5
 3
O08
 72
hr
 1657 1410 5505 0.2561 -0.0644
BT-20 WZ-4-145
3.33
uM
LJP6
 1
J20
 72
hr
 1657 4066 5505 0.7385 0.6259
BT-20 WZ-4-145
3.33
uM
LJP6
 2
J20
 72
hr
 1657 4451 5505 0.8084 0.7259
BT-20 WZ-4-145
3.33
uM
LJP6
 3
J20
 72
hr
 1657 4268 5505 0.7752 0.6784
BT-20 XMD16-144
3.33
uM
LJP5
 1
M08
 72
hr
 1657 1963 5505 0.3565 0.0793
BT-20 XMD16-144
3.33
uM
LJP5
 2
M08
 72
hr
 1657 1999 5505 0.3631 0.0887
BT-20 XMD16-144
3.33
uM
LJP5
 3
M08
 72
hr
 1657 1912 5505 0.3473 0.0661
BT-20 Brivanib
3.33
uM
LJP5
 1
P14
 72
hr
 1657 4901 5505 0.8902 0.8429
BT-20 Brivanib
3.33
uM
LJP5
 2
P14
 72
hr
 1657 4883 5505 0.8869 0.8382
BT-20 Brivanib
3.33
uM
LJP5
 3
P14
 72
hr
 1657 5128 5505 0.9314 0.9019
BT-20 Buparlisib
3.33
uM
LJP5
 1
H02
 72
hr
 1657 1016 5505 0.1845 -0.1668
BT-20 Buparlisib
3.33
uM
LJP5
 2
H02
 72
hr
 1657 1338 5505 0.2430 -0.0831
BT-20 Buparlisib
3.33
uM
LJP5
 3
H02
 72
hr
 1657 1047 5505 0.1902 -0.1587
BT-20 BX-912
3.33
uM
LJP5
 1
L20
 72
hr
 1657 4354 5505 0.7908 0.7007
BT-20 BX-912
3.33
uM
LJP5
 2
L20
 72
hr
 1657 4245 5505 0.7710 0.6724
BT-20 BX-912
3.33
uM
LJP5
 3
L20
 72
hr
 1657 4122 5505 0.7487 0.6404
BT-20 Canertinib
3.33
uM
LJP6
 1
H08
 72
hr
 1657 4161 5505 0.7558 0.6506
BT-20 Canertinib
3.33
uM
LJP6
 2
H08
 72
hr
 1657 3928 5505 0.7135 0.5900
BT-20 Canertinib
3.33
uM
LJP6
 3
H08
 72
hr
 1657 3962 5505 0.7196 0.5988
BT-20 Celastrol
3.33
uM
LJP6
 1
G08
 72
hr
 1657 781 5505 0.1419 -0.2279
BT-20 Celastrol
3.33
uM
LJP6
 2
G08
 72
hr
 1657 953 5505 0.1731 -0.1832